Showing results (161-170 of 197) with videos related to
Sort By:
Pageof 20
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 24, 2018
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeuticsRichard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, et al.Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signalingYeonjin Ko, Mannkyu Hong, Seungbeom Lee, et al.Acta Neuropathologica Communications|February 5, 2021
Protein disulfide isomerase ERp57 protects early muscle denervation in experimental ALSPablo Rozas, Cristina Pinto, Francisca Martínez Traub, et al.Biorxiv : the Preprint Server for Biology|September 18, 2025
General Trends in the Calnexin-Dependent Expression and Pharmacological Rescue of Clinical CFTR VariantsAustin Tedman, John A Olson, Minsoo Kim, et al.Brain : a Journal of Neurology|February 20, 2025
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.Expert Opinion on Drug Discovery|April 9, 2025
Recent developments in cystic fibrosis drug discovery: where are we today?Miquéias Lopes-Pacheco, Ashlyn G Winters, JaNise J Jackson, et al.Journal of the American Chemical Society|December 22, 2017
"Inverse Drug Discovery" Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl FluorosulfatesDavid E Mortenson, Gabriel J Brighty, Lars Plate, et al.Elife|December 11, 2025
General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variantsAustin Tedman, John A Olson, Minsoo Kim, et al.Biorxiv : the Preprint Server for Biology|February 14, 2024
Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1BThierry Touvier, Francesca A Veneri, Anke Claessens, et al.Nature Chemical Biology|December 3, 2021
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthaseBenjamin J Reisman, Hui Guo, Haley E Ramsey, et al.Pageof 20